Researchers have found inhibiting vascular endothelial growth factor A (VEGFA) signalling can mediate psoriasis development in the epidermis and could be a potential target for novel therapies.
List view / Grid view
Université libre de Bruxelles (ULB)
Researchers in Europe have developed a treatment that targets a tumour cell population responsible for therapy resistance and tumour relapse, giving optimism for patients with the most frequent form of cancer.
Cells behave differently when removed from their environments, just as cells that develop in cultures do not behave like cells in living creatures.